Summary Chromophilic renal cell carcinoma is a distinct type of human renal cancer, only recently recognised and defined by its characteristic histomorphological aspect and cytogenetic aberrations. We are the first to report on the establishment and cytogenetic characterisation of a panel of four permanent cell lines, i.e. chromphi-l, -2, -3 and -4, derived from strictly defined renal cell carcinomas (RCCs) of the chromophilic type and kept in continuous culture for up to 5 years. Immunohistochemistry revealed coexpression of vimentin and cytokeratins in all cell lines -the cytokeratin polypeptide patterns, however, varying between the different cell lines. By light and transmission electron microscopy, various amounts of cytoplasmatic glycogen deposition were observed, being most pronounced in chromphi-3 and -4. The mean population doubling time ranged from 24 h (chromphi-1) to 51 h (chromphi-4). Chromphi-1 tumour cells produced slowly growing tumours in nude mice using the subrenal capsule assay. In all cell lines, cytogenetic analysis revealed numerical chromosomal aberrations known to be characteristic for chromophilic RCCs, i.e. loss of the Y chromosome, tri-or tetrasomy of chromosomes 7 and 17 as well as various combinations of additional structural and numerical chromosomal aberrations. Karyological aberrations were least pronounced in chromphi-2 and most complex in chromphi-1.
Renal cell carcinoma (RCC) is the most frequent renal neoplasm in adults, exhibiting an extremely adverse prognosis once the tumour has metastasised and is beyond the reach of curative surgery (deKernion et al., 1978; Maldazys and deKernion, 1986; Neves et al., 1988) . Until recently, RCC had been considered to be a single tumour entity, showing variable histomorphological patterns (Mostofi, 1981) . Based on distinct cytomorphological criteria, however, Thoenes et al. (1986) introduced a refined subclassification of human RCCs, which can reliably be applied in histopathological diagnosis of renal cancer. Thus, the clear cell type of RCC is composed of tumour cells showing a highly transparent ('empty') cytoplasm owing to an abundance of glycogen and lipid. The chromophobe type of RCC is composed of tumour cells showing a finely reticular (not 'empty') cytoplasma and markedly pronounced cell boundaries. The chromophilic type of RCC makes up about 15% of all renal cell cancers (Thoenes et al., 1986) and shows either small basophilic tumour cells poor in cytoplasm or voluminous eosinophilic tumour cells rich in mitochondria. In contrast to the clear cell and chromophobe types of RCC, which perferentially exhibit a compact growth pattern, 80% of the chromophilic RCCs show a tubulopapillary architecture (Thoenes et al., 1986) . Therefore, the papillary type of RCC as defined by Kovacs (1989) using cytogenetic criteria corresponds to the chromophilic type of RCC as previously defined by Thoenes et al. (1986) using cytomorphological criteria. It is important to note, however, that 20% of the chromophilic RCCs show a non-papillary compact growth pattern, whereas clear cell RCCs occasionally exhibit a papillary growth pattern (Thoenes et al., 1986) . Therefore, cytomorphological criteria permit a more conclusive classification of RCCs than structural criteria related to papillary vs non-papillary growth.
The cytomorphological separation between clear cell, chromophobe and chromophilic types of RCC as distinct tumour entities has been further substantiated in the meantime by differences in cytoskeletal composition, enzyme synthesis and, most importantly, by recent progress in molecular pathology demonstrating distinct genetic aberrations within chromosomal and mitochondrial DNA for each tumour type (Yoshida et al., 1986; Carrol et al., 1987; Pitz et al., 1987; Zbar et al., 1987; Kovacs et al., 1988; Thoenes et al., 1988; Storkel et al., 1989; Kovacs et al., 1991; van den Berg et al., 1993; Kovacs, 1993; Latif et al., 1993; Zbar et al., 1994) .
As cell lines are irreplaceable tools for investigations into the biological properties of RCC, a consequent subclassification is also indispensible for RCC cell lines. Previous reports on permanent cell lines (Hoehn and Schroeder, 1978; Matsuda et al., 1979; Naito et al., 1982; Sytkowski et al., 1983; Grossmann et al., 1985; Ebert et al., 1990; Anglard et al., 1992) The cell pellet obtained was suspended in 10 ,l of PBS supplemented with fibrinogen (20 mg ml-'). After careful resuspension, 5 Ml of thrombin dissolved in minimum essential medium (MEM) (20 units ml-') was added. The clot forming after incubation at 370C for 10 min was cut in four pieces and each piece was inserted under the renal capsule of a 6-week-old female nude mouse. After 4 months, the animals were sacrificed and histological examination of kidneys and lungs was performed. ISCN (Mitelman, 1995) . The composite karyotype of each cell line was defined as the most consistent chromosomal presentation in multiple cells, neglecting random losses or gains of individual chromosomes. All marker chromosomes seen in at least three cells were included in the karyotype.
Isolation of clonal subpopulations
Cloning procedures were performed as previously described (Gerharz et al., 1989; Engers et al., 1994) . Briefly, a single-cell suspension of tumour cells was diluted to a concentration of 3 cells ml-', and 0.1 ml of this cell suspension was inoculated into each well of a micro-well plate 96 (Gibco, Eggenstein, Germany). Each well was inspected by inverted microscopy and wells containing a single cell were marked. After incubating the microplates in a moist atmosphere containing 5% carbon dioxide, the developing clones were transferred to a 24-well multidish (Gibco) and further expanded in 25 cm2 flasks. As the cloning efficiency (= ratio between the number of clones obtained and the number of cells seeded) was rather low, cloning experiments were repeated with feeder cells lethally irradiated with 10 000 rad before the inoculation of RCC cells.
Results

Original tumours
The original tumours were typical representatives of the chromophilic type of renal cell carcinoma as defined by Thoenes et al. (1986) . In haematoxylin and eosin-stained sections, the tumours exhibited a tubulopapillary growth pattern with connective tissue axes covered by simple or stratified basophilic (tumours 1,3,4) or eosinophilic (tumour 2) epithelium (Figure 1 ). Tumour 1 showed markedly enlarged nuclei with irregular outlines and prominent nucleoli corresponding to a grade 3 malignancy. Tumours 2 and 3 exhibited only moderately enlarged nuclei, corresponding to grade 2 malignancy. The nuclei of tumour 4 had roughly the size of norlnal tubule cell nuclei, corresponding to grade 1 malignancy. Periodic acid-shift staining revealed no appreciable amounts of glycogen. The cytoskeletal architecture as revealed by immunohistochemistry is summarised in Table III. Cell lines In vitro growth properties The in vitro growth properties of the cell lines chromophi-1, -2, -3, and -4 are summarised in Table IV . The cell line chromphi-1 exhibited the shortest mean population-doubling time, whereas chromphi-4 was the cell line growing most slowly, its mean population-doubling time exceeding 2 days. The saturation density was lowest in chromphi-2 (1.3 x 105 cells cm-2) and highest in chromphi-4 (2 x 105 cells cm-2).
In vitro morphology As shown by scanning electron microscopy (Figure 2 ), all cell lines grow strictly anchorage dependent as monolayers. The tumour cells of all cell lines exhibited a polygonal shape and were either tightly apposed (chromphi-1) or separated by irregular spaces bridged by cytoplasmic microspikes (chromphi-2, -3, and -4).
In contrast to the original tumours, PAS staining revealed glycogen deposition in all cell lines, the amount of glycogen, however, varying from cell line to cell line (Figure 3a -d) . Thus, tumour cells with an intensively positive PAS staining reaction were scattered between tumour cells without appreciable cytoplasmatic staining in chromphi-l and -2. Chromphi-3 and -4 exhibited extensive glycogen deposits in most tumour cells. Transmission electron microscopy confirmed these differences in glycogen deposition showing deposits of monoparticulate glycogen (Figure 3e and f). Mitochondria and profiles of rough endoplasmatic reticulum (Figure 3g ) were distributed rather evenly throughout the cytoplasm, sometimes intermingled with small aggregates of lipid droplets. Desmosome-like junctions were only occasionally observed (Figure 3h) .
Immunocytochemically, all cell lines uniformly showed a cytoplasmic fibrilar staining of essentially all cells with the antibody against vimentin (Figure 4a and b) , but markedly differed in their cytokeratin expression (Table V) . Thus, cytokeratin no. 7 was exclusively observed in chromphi-2 cells (Figure 4c aneuploid (Table VI) . As revealed by cell cycle analysis, the proportion of cells in the G0/G,-phase of the cell cycle ranged from 65% (chromphi-1) to 84% (chromphi-2).
Chromosome analysis Cytogenetic analysis revealed both random and non-random karyotypic changes in all cell lines ( Figure 5 ). The composite karyotypes neglecting random losses or gains of individual chromosomes are presented in Table VII (Hoehn and Schroeder, 1978; Matsuda et al., 1979; Naito et al., 1982; Sytkowski et al., 1983; Grossmann et al., 1985; Ebert et al., 1990; Anglard et al., 1992) (Gerharz et al., 1993; Gerharz et al., 1994; Gerharz et al., 1995) . Here, we present evidence that an analogous conservatism holds true for permanent cell lines derived from the chromophilic type of RCC. All the cell lines consistently exhibited a coexpression of vimentin and cytokeratins, which had been emphasised to be a characteristic feature of chromophilic RCCs in vivo (Pitz et al., 1987) . Analysis of the cytokeratin polypeptide patterns, however, revealed pronounced phenotypic heterogeneity of cytoskeletal composition. In particular, the expression of cytokeratin nos. 7 and 19 varied markedly between the different cell lines as well as between cells of the same cell line. A corresponding cytoskeletal heterogeneity, however, had already been observed for chromophilic RCC in vivo (Pitz et al., 1987) and may be because of intrinsic heterogeneity between different chromophilic RCCs and/or phenotypic modulation by as yet unknown microenvironmental factors. This assumption was further supported by our cloning experiments, which failed to isolate clonal subpopulations with a more homogeneous pattern of cytokeratin expression than the corresponding parental cell lines. Chromphi-4 cells were conspicuous by their comparatively low level of cytokeratin expression, suggesting a more pronounced mesenchymal differentiation component. It was also interesting to note that chromphi-1 cells exhibited a strong expression of cytokeratin no. 20, although cytokeratin no. 20 could be demonstrated in the original tumour only after extensive immunohistochemical screening showing a few positive tumour cells within small blood vessels. Cytokeratin no. 20 is preferentially expressed in gastrointestinal, biliary, pancreatic and urothelial tumours, and has only rarely been observed in RCC in vivo (Moll et al., 1992) . As chromphi-I was derived from a highly malignant G3 tumour and exhibited the most pronounced karyotypic alterations, the expression of cytokeratin no. 20 in this cell line might simply reflect random gene activation during the process of tumour progression. im; e, bar= lIOgm; f, bar=0.5 gm; g and h, bar= 1 pm.
The deposition of large amounts of glycogen is one of the most important cytomorphological criteria for the definition of the clear cell type of RCC (Thoenes et al., 1986; Mayer and Bannasch, 1988) . Thus, a 380-to 840-fold increase in glycogen content was observed in clear cell RCCs when compared with normal kidney tissue (Steinberg et al., 1992) . Nevertheless, randomly scattered tumour cells with glycogen deposits can also be observed in chromophilic RCCs (Thoenes et al., 1986; Hughson et al., 1993) . Biochemical analysis revealed an activation of glycolysis and reduction of gluconeogenesis in both types of RCC, whereas an activation of the pentose phosphate pathway was observed exclusively in chromophilic RCCs, but not in clear cell RCCs (Steinberg et al., 1992 (a,b) in all tumour cells. Positive immunostaining for cytokeratin no. 7 in some tumour cells of chromphi-2 (c, arrows) as opposed to the negative staining reaction in chromphi-4 cells (d). Positive immunostaining for cytokeratin nos. 18 (e,f) and 19 (g,h) , the immunostaining being more intensive in chromphi-2 cells (e,g). Positive immunostaining for cytokeratin no. 20 in sparsely distributed cells of chromphi-2 (i, arrows) as opposed to the negative staining reaction in chromphi-4 (j). a-j, bar=25pum. Despite the increased glycogen deposition, all our cell lines consistently exhibited numerical chromosomal aberrations known to be typical for the chromophilic (papillary) type of RCC (Kovacs, 1989; Kovacs et al., 1991; van den Berg et al., 1993; Kovacs, 1993) . All the cell lines showed gains of chromosomes 7 and 17 combined with a loss of the Y chromosome. Additional numerical and structural chromosomal aberrations were observed in various combinations in all cell lines. None of our cell lines, however, exhibited the loss of a specific chromosomal region at chromosome 3p, known to be the characteristic chromosomal marker of the clear cell type of RCC (Yoshida et al., 1986; Carrol et al., 1987; Zbar et al., 1987; Kovacs et al., 1988) . The gain of chromosomes 7 and 17 combined with the loss of the Y chromosome has been identified as the common denominator of the chromophilic (papillary) renal cell carcinoma and its (Knudson, 1987) , the development of cancer might be associated with a sequence of genetic events resulting in the I I i loss of both wild-type alleles of a tumour suppressor gene. Therefore, it has been hypothesised that a tumour-suppressor gene might be localised at the homologous regions of the X and Y chromosomes (Kovacs et al., 1991; Kovacs, 1993) . In this context, it is interesting to note the strong male preponderance ofchromophilic (papillary) renal cell carcinoma, which has been estimated to be as high as 8: 1 (Kovacs, 1993) , and which also was evident in our investigation. As the mutational inactivation of the putative tumour-suppressor gene at the homologous regions of the X and Y chromosomes should occur at the same frequency by chance, other factors must contribute to the unequal sex distribution of chromophilic RCCs. A possible explanation might be derived from recent observations showing a high frequency of chromosomal mosaicism in normal kidney tissues obtained from patients with renal cancer. A clonal loss of the Y chromosome was observed in 21 out of 31 (68%) normal kidney probes obtained from men as opposed to clonal monosomy X in 1 out of 14 (7%) normal kidney probes obtained from women (Emanuel et al., 1992) . Therefore, precursor cells having only one allele of the putative suppressor gene seem to be more prevalent in male kidneys than in female kidneys, thus probably determining the male preponderance of chromophilic (papillary) RCC (Kovacs et al., 1994) .
On the other hand, the initiation of chromophilic tumour cells could also be related to the polysomy of chromosomes carrying mutant genes, as the amplification of mutant vs Figure 5 Representative karyotypes of chromphi-l (a), chromphi-2 (b), chromphi-3 (c) and chromphi-4 (d). der(2)del(2)(p21 --pter)add(2)(q3?)2x, -3,add(3)(p25)2x, -4, add(6)(q2?), + 7,der(?;8)(?;q10), -9,-11, + 12,del(12)(q15? -qter)2x, -13,der(13)add (13) Chromphi-3
Chromphi-4
Chromophilic renal carcinoma cell lines C-D Gerharz et al x 1613 normal alleles has also been shown to affect cell proliferation and differentiation (Klein, 1981) . So far, however, the genes actually affected by the polysomy of chromosomes 7, 8, 12, 16, 17 and 20 in chromophilic tumours remain to be defined.
In conclusion, the newly established cell lines represent a spectrum of chromophilic RCCs defined by distinct cytomorphological criteria and cytogenetic aberrations, not observed in the clear cell and chromophobe types of RCC. Therefore, these cell lines will become valuable tools for further investigations on the genetic, molecular and biological properties of chromophilic RCCs. Experimental studies analysing the invasive behaviour and the response to biological response modifiers in chromophilic RCCs are currently in progress in our laboratory.
